A SECRET WEAPON FOR NEW ACTIVE PHARMACEUTICAL INGREDIENTS

“As API suppliers, we are a little bit in the center,” Gomes states. “We see what is happening with our clients that are generic or branded drug manufacturers, but we also see what is occurring in the earliest phase of the availability chain.Both Woodcock along with the EFCG delegates spoke of the need to safeguard the planet’s provide of m